MedPath

Study of Risk Factors for the Occurrence and Severity of Exertional Heatstroke in the Military Environment

Recruiting
Conditions
Heat Stroke
Interventions
Other: Saliva collection
Behavioral: Questionnaires
Other: Ingestible core temperature capsule intake
Other: Physical exercise
Other: Heart rate monitoring
Other: Core temperature monitoring
Registration Number
NCT04593316
Lead Sponsor
Direction Centrale du Service de Santé des Armées
Brief Summary

Although the circumstances of onset and management of exertional heatstroke have been identified for several years, its pathophysiology remains imperfectly understood. Exertional heatstroke is the result of both extrinsic (i.e. environmental) and intrinsic (i.e. individual) contributing factors.

Extrinsic factors are well known (high ambient temperature and hygrometry, poorly "breathable" clothing, intense and prolonged physical effort) but some of them may be observed in milder conditions. In the French Armed Forces, 25% of the exertional heatstrokes that have been reported between 2005 and 2011 occurred below 17°C.

Intrinsic factors, on the other hand, are numerous and less consensual, partly because of the imperfect knowledge of exertional heatstroke physiopathology. Potential factors include a thermoregulatory defect (inability to maintain a temperature plateau during an effort) and several genetic mutations may also contribute to explain a propensity to present an exertional heatstroke. While exertional heatstroke is clearly not a monogenic pathology, the association of several polymorphisms could contribute to this vulnerability. Among the genes that have been explored, mutations in ryanodine receptor type 1 (RyR 1), calsequestrin-1 or angiotensin-1 converting enzyme (ACE) appear to be potential candidates. However, it is very likely that other polymorphisms may be involved, such as: genes involved in sports performance and exercise rhabdomyolysis, in the inflammatory cascade, permeability of the digestive epithelial barrier, adenosine receptors and susceptibility to anxiety.

Finally, motivation is a mixed factor often claimed to be involved in exertional heatstroke but has never been quantified and needs to be objectified.

To date, none of these hypotheses has been clearly assessed by comparing patients who experienced exertional heatstroke to healthy subjects.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Active military
  • Between 18 and 45 years old
  • Ability to the walk/run test
Exclusion Criteria
  • Ongoing drug treatment (for the control group only),
  • BMI greater than or equal to 30,
  • Contraindication to the ingestion of a core temperature capsule

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Exertional heatstroke groupCore temperature monitoringPatients presenting or having presented exertional heatstroke.
Control groupIngestible core temperature capsule intakeHealthy people who never experienced exertional heatstroke.
Exertional heatstroke groupQuestionnairesPatients presenting or having presented exertional heatstroke.
Exertional heatstroke groupHeart rate monitoringPatients presenting or having presented exertional heatstroke.
Control groupSaliva collectionHealthy people who never experienced exertional heatstroke.
Control groupPhysical exerciseHealthy people who never experienced exertional heatstroke.
Exertional heatstroke groupSaliva collectionPatients presenting or having presented exertional heatstroke.
Exertional heatstroke groupIngestible core temperature capsule intakePatients presenting or having presented exertional heatstroke.
Exertional heatstroke groupPhysical exercisePatients presenting or having presented exertional heatstroke.
Control groupQuestionnairesHealthy people who never experienced exertional heatstroke.
Control groupHeart rate monitoringHealthy people who never experienced exertional heatstroke.
Control groupCore temperature monitoringHealthy people who never experienced exertional heatstroke.
Primary Outcome Measures
NameTimeMethod
Difference of the frequency of FAAH gene polymorphisms between the heatstroke group and the control groupAt enrollment (day 1)

The frequency of FAAH gene polymorphisms will calculated in each group by dividing the number of participants who present the polymorphism by the total number of participants in the group.

Difference of the frequency of GRIN2B gene polymorphisms between the heatstroke group and the control groupAt enrollment (day 1)

The frequency of GRIN2B gene polymorphisms will calculated in each group by dividing the number of participants who present the polymorphism by the total number of participants in the group.

Difference of the frequency of BDNF gene polymorphisms between the heatstroke group and the control groupAt enrollment (day 1)

The frequency of BDNF gene polymorphisms will calculated in each group by dividing the number of participants who present the polymorphism by the total number of participants in the group.

Difference of the frequency of CYP24A1 gene polymorphisms between the heatstroke group and the control groupAt enrollment (day 1)

The frequency of CYP24A1 gene polymorphisms will calculated in each group by dividing the number of participants who present the polymorphism by the total number of participants in the group.

Difference of the frequency of COMT gene polymorphisms between the heatstroke group and the control groupAt enrollment (day 1)

The frequency of COMT gene polymorphisms will calculated in each group by dividing the number of participants who present the polymorphism by the total number of participants in the group.

Difference of the frequency of TPH2 gene polymorphisms between the heatstroke group and the control groupAt enrollment (day 1)

The frequency of TPH2 gene polymorphisms will calculated in each group by dividing the number of participants who present the polymorphism by the total number of participants in the group.

Difference of the frequency of DRD2 gene polymorphisms between the heatstroke group and the control groupAt enrollment (day 1)

The frequency of DRD2 gene polymorphisms will calculated in each group by dividing the number of participants who present the polymorphism by the total number of participants in the group.

Difference of the frequency of PER3 gene polymorphisms between the heatstroke group and the control groupAt enrollment (day 1)

The frequency of PER3 gene polymorphisms will calculated in each group by dividing the number of participants who present the polymorphism by the total number of participants in the group.

Difference of the frequency of IL1B gene polymorphisms between the heatstroke group and the control groupAt enrollment (day 1)

The frequency of IL1B gene polymorphisms will calculated in each group by dividing the number of participants who present the polymorphism by the total number of participants in the group.

Difference of the frequency of HSPA1B gene polymorphisms between the heatstroke group and the control groupAt enrollment (day 1)

The frequency of HSPA1B gene polymorphisms will calculated in each group by dividing the number of participants who present the polymorphism by the total number of participants in the group.

Difference of the frequency of TNF-a gene polymorphisms between the heatstroke group and the control groupAt enrollment (day 1)

The frequency of TNF-a gene polymorphisms will calculated in each group by dividing the number of participants who present the polymorphism by the total number of participants in the group.

Difference of the frequency of TLR4 gene polymorphisms between the heatstroke group and the control groupAt enrollment (day 1)

The frequency of TLR4 gene polymorphisms will calculated in each group by dividing the number of participants who present the polymorphism by the total number of participants in the group.

Difference of the frequency of IL-6 gene polymorphisms between the heatstroke group and the control groupAt enrollment (day 1)

The frequency of IL-6 gene polymorphisms will calculated in each group by dividing the number of participants who present the polymorphism by the total number of participants in the group.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

Hôpital d'Instruction des Armées Laveran

🇫🇷

Marseille, France

Institut de Recherche Biomédicale des Armées

🇫🇷

Brétigny-sur-Orge, France

Ecole du Val-de-Grâce

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath